1. Abate D, Cesaro S, Cofano S, Fiscon M, Saldan A, Varotto S, Mengoli C, Pillon M, Calore E, Biasolo MA, Cusinato R, Barzon L, Messina C, Carli M, Palu G (2012) Diagnostic utility of human cytomegalovirus-specific T-cell response monitoring in predicting viremia in pediatric allogeneic stem-cell transplant patients. Transplantation 93:536–542
2. Aoki J, Numata A, Yamamoto E, Fujii E, Tanaka M, Kanamori H (2015) Impact of human Herpesvirus-6 reactivation on outcomes of allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 21:2017–2022
3. Appleton AL, Sviland L, Peiris JS, Taylor CE, Wilkes J, Green MA, Pearson AD, Kelly PJ, Malcolm AJ, Proctor SJ et al (1995) Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne bone marrow transport group. Bone Marrow Transplant 16:777–782
4. Asano Y, Yoshikawa T, Suga S, Yazaki T, Kondo k, Yamanishi K (1990) Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection. Lancet 335:862–863
5. Asano Y, Yoshikawa T, Suga S, Nakashima T, Yazaki T, Fukuda M, Kojima S, Matsuyama T (1991) Reactivation of herpesvirus type 6 in children receiving bone marrow transplants for leukemia. N Engl J Med 324:634–635